From Printer to Patient: The 3D Printed Microarray Devices Shaping Tomorrow’s Precision Health Har passerat
Onsdag 21 maj 2025 09:30 - 10:00 F2
Föreläsare: Gunilla JacobsonSpår: AI in Precision health
Leveraging high-resolution 3D printing, we are redefining how treatments are administered, enhancing patient comfort, and driving better health outcomes. Our innovative microneedle array platform integrates real-time biomarker monitoring with controlled drug delivery, transforming disease prevention, treatment, and personalized medicine. By replacing traditional blood draws with painless, minimally invasive, and cost-effective 3D-printed microneedle patches, we enable biomarker sampling from interstitial fluid (ISF)—a rich source of molecular information comparable to blood. Beyond diagnostics, this microarray platform enables targeted, needle-free delivery of vaccines and therapeutics into the intradermal space, offering a scalable and adaptable approach to vaccination and treatments. Our goal is to advance precision health by making continuous monitoring and proactive care more accessible, beyond a hospital setting.
Ämne
Framtidens hälsa, omsorg och vård
Seminarietyp
Live + på plats
Föreläsningsformat
Presentation
Föreläsningssyfte
Orientering
Kunskapsnivå
Fördjupning
Målgrupp
Chef/Beslutsfattare
Forskare (även studerande)
Omsorgspersonal
Vårdpersonal
Nyckelord
Exempel från verkligheten (goda/dåliga)
Nytta/effekt
Innovation/forskning
Informatik/Interoperabilitet
Föreläsare
Gunilla Jacobson Föreläsare
Director of Translational Medicine, Dept of Radiology, School of Medicine
Stanford University
Dr. Jacobson has a PhD in organic chemistry from Uppsala University in Sweden, has held several academic positions at Stanford University and the Karolinska Institute, and is a Docent in Chemistry at Uppsala University. She has 25 years’ experience of translating research from academia, industry, and government laboratories to scalable products. This includes translation of diagnostic probes to first-in-human studies under FDA approval.
Within the Department of Radiology at Stanford, she leads several initiatives focused on innovations in the areas of precision medicine and precision health, with the goal of developing methods for early detection of disease, targeted and specific treatments of disease, and ways to predict disease to sustain health and prevent illness.